Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Bridging the COPD awareness gap in marginalized populations: Findings from a multicentre study in Khalilabad, Sant Kabir Nagar, Uttar Pradesh, India

View through CrossRef
Sant Kabir Nagar, a district in Uttar Pradesh, India, faces significant healthcare challenges, particularly in managing Chronic Obstructive Pulmonary Disease (COPD). This study highlights the alarming lack of COPD awareness, with only 3% of patients recognizing their condition, while 54% had no knowledge and 43% refused diagnosis. Major risk factors include biomass fuel exposure (47.8%), agricultural pollution (32%), and smoking (13.4%). Despite global preference for inhalation therapy, only 9% of patients in Khalilabad, Sant Kabir Nagar receive optimal bronchodilator treatment, with 42% relying on oral medications due to cost, misconceptions, and poor accessibility. The “Difficult Doctor, Difficult Patient, and Difficult Treatment” phenomenon further hampers COPD management. Misconceptions about inhalers, financial constraints, and inadequate physician training lead to underdiagnosis and suboptimal treatment. Key recommendations include nationwide awareness campaigns, spirometry training for physicians, and government-led initiatives to promote inhaler use. Subsidizing inhalation therapy could significantly improve adherence and patient outcomes. Immediate action is essential to bridge the COPD treatment gap in Khalilabad, Sant Kabir Nagar. By addressing financial, educational, and medical barriers, policymakers and healthcare professionals can enhance early detection, improve treatment strategies, and ultimately reduce the disease burden, leading to better health outcomes and quality of life for affected individuals.
Title: Bridging the COPD awareness gap in marginalized populations: Findings from a multicentre study in Khalilabad, Sant Kabir Nagar, Uttar Pradesh, India
Description:
Sant Kabir Nagar, a district in Uttar Pradesh, India, faces significant healthcare challenges, particularly in managing Chronic Obstructive Pulmonary Disease (COPD).
This study highlights the alarming lack of COPD awareness, with only 3% of patients recognizing their condition, while 54% had no knowledge and 43% refused diagnosis.
Major risk factors include biomass fuel exposure (47.
8%), agricultural pollution (32%), and smoking (13.
4%).
Despite global preference for inhalation therapy, only 9% of patients in Khalilabad, Sant Kabir Nagar receive optimal bronchodilator treatment, with 42% relying on oral medications due to cost, misconceptions, and poor accessibility.
The “Difficult Doctor, Difficult Patient, and Difficult Treatment” phenomenon further hampers COPD management.
Misconceptions about inhalers, financial constraints, and inadequate physician training lead to underdiagnosis and suboptimal treatment.
Key recommendations include nationwide awareness campaigns, spirometry training for physicians, and government-led initiatives to promote inhaler use.
Subsidizing inhalation therapy could significantly improve adherence and patient outcomes.
Immediate action is essential to bridge the COPD treatment gap in Khalilabad, Sant Kabir Nagar.
By addressing financial, educational, and medical barriers, policymakers and healthcare professionals can enhance early detection, improve treatment strategies, and ultimately reduce the disease burden, leading to better health outcomes and quality of life for affected individuals.

Related Results

Innate immunity and its link to clinical outcomes in smokers with and without COPD
Innate immunity and its link to clinical outcomes in smokers with and without COPD
<p dir="ltr">Chronic obstructive pulmonary disease (COPD) is the fourth most common causes of death globally, affecting around ten percent of the adult population. Patients w...
Innate immunity and its link to clinical outcomes in smokers with and without COPD
Innate immunity and its link to clinical outcomes in smokers with and without COPD
<p dir="ltr">Chronic obstructive pulmonary disease (COPD) is the fourth most common causes of death globally, affecting around ten percent of the adult population. Patients w...
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Abstract Background: COPD is a well-known risk factor for lung cancer, independent of smoking behavior. By investigating the retrospective National Health Insurance Service...
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Abstract Background: COPD is a well-known risk factor for lung cancer, independent of smoking behavior. By investigating the retrospective National Health Insurance Service...
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Abstract Background: COPD is a well-known risk factor for lung cancer, independent of smoking behavior. By investigating the retrospective National Health Insurance Service...
Irreversible Airflow Limitation in Elderly Adults with a History of Severe Childhood Asthma – COPD-A, COPD-C or?
Irreversible Airflow Limitation in Elderly Adults with a History of Severe Childhood Asthma – COPD-A, COPD-C or?
Abstract Background According to the GOLD 2023 strategy paper, classification of chronic obstructive pulmonary disease (COPD) may include distinct COPD types. We applied t...
Current Perspectives on Cystic Echinococcosis: A Systematic Review
Current Perspectives on Cystic Echinococcosis: A Systematic Review
Abstract Introduction: Hydatidosis, a zoonotic disease caused by the larval stage of Echinococcus granulosus, is a significant public health concern with notable economic impact. I...

Back to Top